Immunomedics Inc - Company Profile
Powered by 
All the data and insights you need on Immunomedics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Immunomedics Inc Strategy Report
- Understand Immunomedics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Immunomedics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 Aug 2022 | Gilead Sciences to Receive Rights of Trodelvy from Everest Medicines | Licensing Agreement |
Immunomedics Inc
|
Everest Medicines Ltd
|
| 20 Oct 2020 | Immunomedics Enters into Licensing Agreement with ProteoNic | Licensing Agreement |
Immunomedics Inc
|
ProteoNic BV
|
| 13 Sep 2020 | Gilead Sciences Acquires Immunomedics | Acquisition |
Gilead Sciences Inc
|
Immunomedics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer